Welcome to
RBP World!
Drugs target to METAP2
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| TOSEDOSTAT | Small molecule | pancreatic carcinoma | Aminopeptidase inhibitor | 1.0 | Terminated | ClinicalTrials |
| TOSEDOSTAT | Small molecule | myelodysplastic syndrome | Aminopeptidase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELORANIB | Small molecule | obesity | Methionine aminopeptidase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| TOSEDOSTAT | Small molecule | acute myeloid leukemia | Aminopeptidase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| BELORANIB | Small molecule | Prader-Willi syndrome | Methionine aminopeptidase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| TOSEDOSTAT | Small molecule | neoplasm | Aminopeptidase inhibitor | 1.0 | Completed | ClinicalTrials |
| TOSEDOSTAT | Small molecule | non-small cell lung carcinoma | Aminopeptidase inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELORANIB | Small molecule | Prader-Willi syndrome | Methionine aminopeptidase 2 inhibitor | 3.0 | Terminated | ClinicalTrials |
| BELORANIB | Small molecule | obesity | Methionine aminopeptidase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| TOSEDOSTAT | Small molecule | acute myeloid leukemia | Aminopeptidase inhibitor | 2.0 | Completed | ClinicalTrials |